Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Upcoming Catalysts Matter For Full House Fll Stock Price At 2.46 Down 8.70 20260410 Ramp Uptrend Accelerates On Sector 20260403 1 Should I Buy Ridenow Group Rdnw Stock In 2026 Price At 7.03 Up 3.69 20260406 Can Upstart Upst Stock Double In 2026 Price At 26.91 Up 5.18 20260406 Is Mediaalpha Max Stock A Market Leader Price At 9.29 Down 0.75 20260406 Market Update Tech leads gains as consumer sector lags market ASPSW Altisource quarterly earnings report shows stakeholder warrant activity as company navigates market challenges Affiliated MGRB Stock Value Opportunity Bearish Sentiment 20260416 Is Karyopharm Therapeutics KPTI stock considered a safe play Q4 2025 Below Expectations AARD Aardvark posts narrower than expected Q4 2025 loss shares rise more than four percent today LASR nLIGHT tops Q4 2025 EPS estimates by 248 percent shares rise 129 percent on positive investor reaction VSTM Verastem quarterly report shows zero revenue but management highlights clinical trial progress and upcoming milestones Root ROOT Stock Is It Overvalued Root swings to surprise profit on massive EPS beat UroGen Pharma URGN Stock Trending Up Gains 20260422 The hidden strength in PRA Group PRAA most investors miss Touches Low 20260506 The long term thesis for Monopar Therapeutics MNPR in plain sight Smart Money Outflows 20260508 MGEE MGE Energy posts narrow Q4 2025 EPS miss against estimates while shares edge higher on positive investor sentiment MCY Mercury surges 61 above estimates on Q1 EPS beat but stock gains only 2 as investors seek caution The edge Zscaler ZS has in a competitive landscape Skyrockets 20260508 MuskAltman Trial Exposes Rivalries and Governance Questions in AI Sector NFL Urges CFTC to Ban Certain Sports Prediction Markets Contracts to Protect League Integrity US Inflation Accelerates to 38 in April Amid Iran Conflict CPI Data Shows FormFactor FORM Reports Strong Q1 2026 Revenue NA EPS Beats Zentek ZTEK Rallies 072 as Bulls Target 072 20260518 Indian Market Surges Over 800 Points on Sensex Nagaraj Shetti Recommends NMDC NTPC Green Global GIC Climbs 061 Resistance at 3033 in Focus 20260518 Capricor CAPR Q1 2026 Results Fall Short EPS 059 Revenue NA Jim Cramer Calls for Strategic Portfolio Shifts Highlights Significant Upside Potential in Select Names Chinas Diplomatic Balancing Act Mirrored Welcomes for Trump and Putin Signal Strategic Stability for Global Markets Varonis Systems VRNS Delivers Q1 2026 Beat EPS 006 vs 005 Expected Kevin Warsh Faces Divided FOMC as Inflation and Treasury Yields Rise Japan Carmakers Face Margin Pressure as Aluminum Prices Surge Supply Risks Loom Nvidia Revenue Surge Continues Amid AI Chip Demand Growth NFL Seeks Ban on Certain Sports Prediction Contracts Including GameSpecific Bets and Injury Markets Accenture and HUMAIN Forge Strategic Partnership to Boost AI Adoption in Saudi Arabia Bond Market Signals Inflation Concerns as Kevin Warsh Assumes Fed Leadership ALOY Q1 2024 Earnings EPS Misses Estimates Sharply Stock Rises on No Revenue Disclosure RWT Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction MPT Q1 2026 Earnings EPS Surges Past Estimates With 65 Beat Stock Slides Slightly TWAV Q3 2022 Earnings Deep Loss Exceeds Expectations Stock Drops 76 PRTH Q1 2026 Earnings EPS Surges 277 Above Estimates Shares Rally Immutep IMMP Shares Slide 66 as Biotech Stock Tests Key Support at 043 Above Food Ingredients Inc ABVE Surges 9 as Buyers Test Key Resistance Personalis Inc PSNL Surges 45 as Stock Tests Key Resistance Near 905 Chain Bridge Bancorp CBNA Slides 177 as Stock Tests Key Support Levels RPRX Royalty posts Q4 2025 87 percent EPS beat and 51 percent YoY revenue gain shares edge down Atlas Energy AESI Stock High Yield Technical Strength 20260420 IINNW Inspira details long term respiratory care market growth strategies in its latest quarterly earnings report Is Hilton HLT stock picking up momentum Hilton posts 2pct EPS beat on strong travel demand What Wall Street expects from UroGen Pharma URGN this quarter Q1 2026 EPS Exceeds Expectations